Evidence map›Paper›PMID 33566156›Full record

ArticleMikrochimica acta2021

2D metal azolate framework as nanozyme for amperometric detection of glucose at physiological pH and alkaline medium.

Muhammad Adeel, Vincenzo Canzonieri, Salvatore Daniele, Alberto Vomiero, Flavio Rizzolio, Md Mahbubur Rahman

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Nanozymes-Hitting the Biosensing "Target".Sensors (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Muhammad AdeelDepartment of Molecular Sciences and Nanosystems, Ca'Foscari University of Venice, 30172, Venice-Mestre, Italy.
Vincenzo CanzonieriPathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081, Aviano, Italy.
Salvatore DanieleDepartment of Molecular Sciences and Nanosystems, Ca'Foscari University of Venice, 30172, Venice-Mestre, Italy.
Alberto VomieroDepartment of Molecular Sciences and Nanosystems, Ca'Foscari University of Venice, 30172, Venice-Mestre, Italy. alberto.vomiero@ltu.se.
Flavio RizzolioDepartment of Molecular Sciences and Nanosystems, Ca'Foscari University of Venice, 30172, Venice-Mestre, Italy. flavio.rizzolio@unive.it.
Md Mahbubur RahmanDepartment of Energy and Materials, Konkuk University, Chungju, 27478, Republic of Korea. mahbub1982@kku.ac.kr.ORCID 0000-0003-0012-5324
Ca' Foscari University of Venice · ITKonkuk University · KRUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of Co-based two-dimensional (2D) metal azolate framework nanosheets (MAF-5-Co

Indexed as

Blood GlucoseCatalysisCobaltElectrochemical TechniquesElectrodesHumansHydrogen-Ion ConcentrationLimit of DetectionMetal-Organic FrameworksNanostructuresOxidation-ReductionReproducibility of ResultsBlood GlucoseCobaltMetal-Organic FrameworksChronoamperometryGlucose detectionHuman blood plasmaMetal azolate frameworkNeutral and alkaline conditions

Identifiers

PMID33566156
OpenAlexW3127227839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.